Brand tirzepatide retails for roughly $1,069\/month for Mounjaro\u00ae and $1,086\/month for Zepbound\u00ae pens at list price without insurance, per Eli Lilly pricing as of 2025. Eli Lilly’s direct cash pay program (LillyDirect) offers Zepbound vials at $349-$499\/month for the 2.5 mg and 5 mg doses. Compounded tirzepatide through telehealth typically runs $279-$499\/month depending on dose.<\/p>\n
Insurance coverage for brand tirzepatide is inconsistent. Most commercial plans cover Mounjaro for type 2 diabetes but exclude Zepbound for weight loss. Medicare Part D excludes anti-obesity medications by statute. Medicaid coverage varies. Most cash-pay patients without prior authorization pay full retail or use the LillyDirect cash program.<\/p>\n
This breakdown covers brand pricing, compounded pricing, insurance landscape, savings programs, and total cost considerations.<\/p>\n
At TrimRx, we believe that understanding your options is the first step toward a more manageable health journey. You can take the free assessment quiz if you’re ready to see whether a personalized program is a fit for you.<\/p>\n
Zepbound list price is $1,086.37 per 28-day supply pen package regardless of dose strength.<\/strong> Mounjaro is $1,069.08 per 28-day supply. Both are set by Eli Lilly and apply uniformly across all dose strengths (2.5, 5, 7.5, 10, 12.5, 15 mg).<\/p>\n Quick Answer: Zepbound list price: $1,086\/month; Mounjaro: $1,069\/month<\/p>\n Major pharmacies carry both. Cash prices may vary by 5-15% from list. Costco often runs slightly below list. GoodRx coupons offer minimal discount on brand GLP-1s, typically under 5%, because Eli Lilly doesn’t participate in discount card networks at meaningful levels.<\/p>\n Over a full year at retail, Zepbound costs about $13,032 and Mounjaro about $12,829. For 18 months (typical to reach full response), that’s $20,000-$24,000 out of pocket without insurance.<\/p>\n Eli Lilly launched LillyDirect in 2024 as a direct-to-consumer cash pay channel for Zepbound.<\/strong> It offers Zepbound vials (not pens) at $349\/month for 2.5 mg and $499\/month for 5 mg. As of mid-2025 LillyDirect has not extended cash pricing to higher doses (7.5, 10, 12.5, 15 mg).<\/p>\n The vials require a U-100 insulin syringe, similar to compounded products. This makes the cash-pay vial route cost-competitive with compounded preparations for the lower doses. For higher doses, only the standard pen pricing applies.<\/p>\n LillyDirect is open to commercial and uninsured patients with a valid prescription. Government insurance patients (Medicare, Medicaid, VA) cannot use it.<\/p>\n Compounded tirzepatide bypasses the brand markup.<\/strong> The active ingredient costs the compounding pharmacy a small fraction of retail price. Without R&D recovery, marketing, and brand profit margins, the same molecule can be prepared and shipped for $279-$499\/month.<\/p>\n Compounding became legal at scale because of the FDA shortage list. Tirzepatide was added to shortage in late 2022. In October 2024 the FDA removed tirzepatide from the shortage list, which initially threatened compounded supply, but federal court rulings in late 2024 and state pharmacy board guidance have allowed continued compounding under section 503A for clinically justified individualized prescriptions.<\/p>\n Typical telehealth pricing as of 2025: $279-$329\/month for 2.5-5 mg, $349-$429 for 7.5-10 mg, and $399-$499 for 12.5-15 mg. TrimRx offers transparent pricing as part of the personalized treatment plan, with a free assessment quiz to determine eligibility.<\/p>\n Mounjaro coverage for type 2 diabetes is broad.<\/strong> Most commercial plans, Medicare Part D, and Medicaid programs cover Mounjaro when prescribed with documented A1c above 6.5% indicating diabetes.<\/p>\n Zepbound coverage for weight loss is patchy. Roughly 30-40% of commercial plans cover Zepbound with prior authorization, requiring documented BMI \u226530 (or \u226527 with comorbidities) and ongoing diet and exercise programs. Self-funded employer plans often exclude anti-obesity medications. State Medicaid coverage for Zepbound is limited.<\/p>\n Medicare Part D cannot cover Zepbound except for the obstructive sleep apnea indication added in December 2024 based on SURMOUNT-OSA. This narrow indication has expanded Medicare access modestly. The weight-only indication remains uncovered under federal statute.<\/p>\n The Zepbound savings card brings out-of-pocket cost to $25\/month for commercially insured patients whose plans cover Zepbound.<\/strong> For commercially insured patients whose plans don’t cover Zepbound, the card offers up to $550 off per fill, bringing cost to roughly $536\/month.<\/p>\n The Mounjaro savings card offers similar tiered savings: $25\/month for covered commercial insurance patients (annual cap), and up to $573 off per fill for uncovered commercial patients.<\/p>\n Government insurance patients (Medicare, Medicaid, VA, Tricare) cannot use the manufacturer savings card. Cash-pay patients without commercial insurance don’t qualify for the highest tier of savings.<\/p>\n For a typical 18-month course to reach and maintain full response:<\/p>\n Compounded tirzepatide: $279-$499\/month \u00d7 18 = $5,022-$8,982 total<\/p>\n LillyDirect Zepbound vials (5 mg dose, suitable for many maintenance patients): $499\/month \u00d7 18 = $8,982<\/p>\n Zepbound with savings card and uncovered commercial insurance: $536\/month \u00d7 18 = $9,648<\/p>\n Zepbound at full retail: $1,086\/month \u00d7 18 = $19,548<\/p>\n Zepbound with savings card and covered commercial insurance: $25\/month \u00d7 18 = $450 (annual cap may reset)<\/p>\n For long-term maintenance past the initial titration year, similar per-month costs continue. Many patients budget $3,300-$6,000 annually for compounded tirzepatide maintenance or $0-$3,000 for covered Zepbound.<\/p>\n A 2024 cost-effectiveness analysis in JAMA Network Open found that tirzepatide at retail prices is not cost-effective at standard willingness-to-pay thresholds for weight loss alone.<\/strong> When metabolic and cardiovascular benefits are included, cost-effectiveness improves but still exceeds typical thresholds.<\/p>\n At compounded or LillyDirect pricing, the math changes. Both routes produce the same drug exposure at 25-50% of pen retail price, putting them in cost-effective range for weight loss and metabolic benefits.<\/p>\n That said, brand and compounded are not regulatory equivalents. Brand tirzepatide has FDA approval for specific indications with manufacturer-controlled quality assurance. Compounded preparations are state-pharmacy regulated, lot-by-lot. The cost gap reflects regulatory pathway, not chemistry.<\/p>\n Key Takeaway: Compounded tirzepatide typically $279-$499\/month through telehealth<\/p>\n Patient assistance programs through Eli Lilly’s Lilly Cares Foundation cover uninsured patients earning under approximately 400% of federal poverty level (about $60,240 for a single person in 2025).<\/strong> The program provides Zepbound at no cost for qualifying patients but requires income documentation and physician application.<\/p>\n HSA and FSA accounts cover prescription GLP-1 medications including compounded versions when prescribed for a qualifying medical condition. Pre-tax savings effectively reduce cost by 20-37% depending on tax bracket.<\/p>\n Some employers offer obesity care benefits through specialized programs. Check with HR for weight management benefits, which sometimes cover Zepbound or telehealth programs even when general medical insurance excludes anti-obesity drugs.<\/p>\n Verify the pharmacy is properly licensed.<\/strong> For compounded tirzepatide, ask whether the pharmacy is 503A (traditional compounding) or 503B (FDA-registered outsourcing facility), the state where it operates, and whether they perform third-party potency and sterility testing.<\/p>\n Ask about all-in pricing. The advertised monthly price should include the medication, provider visits, syringes, and shipping. Hidden fees for re-evaluation, refills, or shipping can add 10-30% to the headline price at some platforms.<\/p>\n Confirm refill flexibility and cancellation policy. Some platforms require 3-6 month commitments. Lock-ins are not standard and shouldn’t be necessary for a chronic medication.<\/p>\n Most telehealth platforms charge an all-in monthly fee that bundles medication, provider visits, syringes, and shipping.<\/strong> A few break these out separately. The all-in approach makes comparison easier.<\/p>\n Typical fee structures:<\/p>\n Some platforms require a 3-6 month commitment with a single payment; others offer monthly billing. Monthly billing with cancel-anytime option is generally more patient-friendly.<\/p>\n Eligibility labs are usually not included in the headline monthly price.<\/strong> Most platforms accept labs from your primary care provider or partner with direct-to-consumer labs (Quest, LabCorp) for affordable testing.<\/p>\n Typical eligibility labs include A1c, complete metabolic panel, and lipid panel. Cash price at DTC labs runs $50-$150 for the full set. Insurance often covers these labs when ordered through primary care.<\/p>\n Follow-up labs at 3-6 months are typical for ongoing monitoring. Same cost structure applies.<\/p>\n Treat tirzepatide like a long-term medication, similar to a statin or blood pressure drug.<\/strong> The total cost matters but so does sustainability. Switching pharmacies mid-treatment is fine, but disruptions to dosing can set back progress.<\/p>\n Many patients budget around $300-$500\/month for compounded tirzepatide as a fixed monthly expense. Insurance-covered brand can be cheaper but is also subject to formulary changes year over year.<\/p>\n The metabolic, sleep apnea, heart failure, and emerging cardiovascular benefits strengthen the value case for long-term maintenance.<\/p>\n Bottom line: Lilly savings card brings Zepbound to $25\/month for commercially insured patients ($550 max savings per fill for uncovered)<\/p>\n Pen brand prices reflect R&D, FDA approval, marketing, manufacturer profit, and US healthcare market pricing. LillyDirect cash vials and compounded versions skip pen device cost and use simpler distribution channels.<\/p>\n Rarely. Compounded medications aren’t on standard insurance formularies because they’re individualized prescriptions, not FDA-approved drugs with NDC codes. HSA\/FSA accounts often reimburse them, but standard commercial insurance does not.<\/p>\n Yes. The active ingredient is the same. Your prescriber can write for Zepbound or LillyDirect vials once you decide to switch. Continue at the same dose level; no re-titration needed.<\/p>\n Not much. GoodRx coupons on Zepbound are typically under 5% off list. The Lilly savings card offers far better savings for eligible commercial insurance patients.<\/p>\n Some prices have risen in 2024-2025 as compounding pharmacies face stricter FDA enforcement and supply chain costs. The range has shifted upward from $279-$399 to $329-$499 at many platforms. Brand prices have held relatively flat.<\/p>\n For commercially insured patients with Zepbound coverage and the savings card, $25\/month is possible. For uninsured or government-insured patients, LillyDirect vials at $349-$499 or compounded tirzepatide at $279-$499 are the lowest-cost legitimate routes. Avoid unlicensed online pharmacies.<\/p>\n Bipartisan legislation has been introduced to allow Medicare Part D to cover anti-obesity medications, but none has passed as of 2025. The 2024 OSA indication opened limited Medicare access for sleep apnea patients but the broader weight indication remains excluded.<\/p>\n Disclaimer:<\/strong> This content is for informational purposes only and does not constitute medical advice. It is not intended to diagnose, treat, cure, or prevent any disease or condition. Individual results may vary. Always consult a qualified healthcare professional before starting any weight loss program or medication.<\/p>\n <\/p>\n Introduction Brand tirzepatide retails for roughly $1,069\/month for Mounjaro\u00ae and $1,086\/month for Zepbound\u00ae pens at list price without insurance, per Eli Lilly pricing as…<\/p>\n","protected":false},"author":11,"featured_media":92701,"comment_status":"closed","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"inline_featured_image":false,"_yoast_wpseo_title":"Compounded Tirzepatide Cost Breakdown: Brand, Compounded, Insurance & Savings Options","_yoast_wpseo_metadesc":"Brand tirzepatide retails for roughly $1,069\/month for Mounjaro\u00ae and $1,086\/month for Zepbound\u00ae pens at list price without insurance, per Eli Lilly...","_yoast_wpseo_focuskw":"compounded tirzepatide cost","footnotes":"","_flyrank_wpseo_metadesc":""},"categories":[9],"tags":[22,23,30,52],"class_list":["post-89345","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-tirzepatide","tag-compounded","tag-cost-coverage","tag-insurance","tag-tirzepatide"],"_links":{"self":[{"href":"https:\/\/trimrx.com\/blog\/wp-json\/wp\/v2\/posts\/89345","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/trimrx.com\/blog\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/trimrx.com\/blog\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/trimrx.com\/blog\/wp-json\/wp\/v2\/users\/11"}],"replies":[{"embeddable":true,"href":"https:\/\/trimrx.com\/blog\/wp-json\/wp\/v2\/comments?post=89345"}],"version-history":[{"count":4,"href":"https:\/\/trimrx.com\/blog\/wp-json\/wp\/v2\/posts\/89345\/revisions"}],"predecessor-version":[{"id":93702,"href":"https:\/\/trimrx.com\/blog\/wp-json\/wp\/v2\/posts\/89345\/revisions\/93702"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/trimrx.com\/blog\/wp-json\/wp\/v2\/media\/92701"}],"wp:attachment":[{"href":"https:\/\/trimrx.com\/blog\/wp-json\/wp\/v2\/media?parent=89345"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/trimrx.com\/blog\/wp-json\/wp\/v2\/categories?post=89345"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/trimrx.com\/blog\/wp-json\/wp\/v2\/tags?post=89345"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}What Is LillyDirect and How Does It Compare?<\/h2>\n
Why Is Compounded Tirzepatide Cheaper Than Brand Pens?<\/h2>\n
What Insurance Plans Cover Mounjaro or Zepbound?<\/h2>\n
How Does the Lilly Savings Card Work?<\/h2>\n
What Are Realistic Monthly Budgets?<\/h2>\n
What About the Long-term Value Question?<\/h2>\n
Are There Other Ways to Save?<\/h2>\n
What Questions Should I Ask Before Starting?<\/h2>\n
How Do Telehealth Platform Fees Compare?<\/h2>\n
\n
What About Lab Costs?<\/h2>\n
How Should I Think About Year-over-year Costs?<\/h2>\n
FAQ<\/h2>\n
Why Is Brand Tirzepatide So Much More Expensive Than Compounded or LillyDirect?<\/h3>\n
Will Insurance Ever Cover Compounded Tirzepatide?<\/h3>\n
Can I Switch From Compounded to LillyDirect or Brand If I Want?<\/h3>\n
Is GoodRx Useful for Zepbound?<\/h3>\n
Are Compounded Prices Going Up?<\/h3>\n
What’s the Cheapest Legitimate Option for Tirzepatide?<\/h3>\n
Will Medicare Cover Zepbound in the Future?<\/h3>\n
Related Articles<\/h2>\n
\n